Affordable Access

Publisher Website

In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro).

Authors
  • Khan, Abbas1
  • Heng, Wang1
  • Wang, Yanjing1
  • Qiu, Jingfei2
  • Wei, Xiaoyong2
  • Peng, Shaoliang2
  • Saleem, Shoaib3
  • Khan, Mazhar4
  • Ali, Syed Shujait5
  • Wei, Dong-Qing1, 2, 6
  • 1 Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. , (China)
  • 2 Peng Cheng Laboratory, Shenzhen, China. , (China)
  • 3 National Center for Bioinformatics, Quaid-i-Azam University, Islamabad, Pakistan. , (Pakistan)
  • 4 The CAS Key Laboratory of Innate Immunity and Chronic Diseases, Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, CAS Center for Excellence in Molecular Cell Science, University of Science and Technology of China (USTC), Collaborative Innovation Center of Genetics and Development, Hefei, China. , (China)
  • 5 Center for Biotechnology and Microbiology, University of Swat, Swat, Pakistan. , (Pakistan)
  • 6 State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. , (China)
Type
Published Article
Journal
Phytotherapy Research
Publisher
Wiley (John Wiley & Sons)
Publication Date
Jun 01, 2021
Volume
35
Issue
6
Pages
2841–2845
Identifiers
DOI: 10.1002/ptr.6998
PMID: 33448101
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times